In the News January 5, 2020

The Pink Sheet | US FDA Getting Faster at Notifying Drug Facility Owners of Inspection Status

Cathy Burgess is referenced for commenting at a Food and Drug Law Institute conference on the timing for declaring a drug manufacturing facility as “official action indicated” following inspection by the U.S. Food and Drug Administration.
Media Contact
Mariana Loose
Chief Marketing Officer
Phone: 212.210.9561

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.